(Q38701186)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780491%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS Barriers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780491%20AND%20SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

5 March 2020

main subject

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780491%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Fabiola Puentes

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780491%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Andrea Malaspina

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780491%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Johannes M van Noort

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780491%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

1 March 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780491%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780491%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780491%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780491%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

248-257

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780491%20AND%20SRC:MED&resulttype=core&format=json

CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS.

5 March 2020

cites work

1 reference

Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis

21 January 2018

1 reference

Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis

21 January 2018

1 reference

Alpha-B-crystallin induces an immune-regulatory and antiviral microglial response in preactive multiple sclerosis lesions

21 January 2018

1 reference

Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.

21 January 2018

1 reference

Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels

21 January 2018

1 reference

Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue

21 January 2018

1 reference

Factors affecting the diagnostic delay in amyotrophic lateral sclerosis.

21 January 2018

1 reference

Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice

21 January 2018

1 reference

TRP channels as cellular sensors

21 January 2018

1 reference

Inflammation Induces TDP-43 Mislocalization and Aggregation

21 January 2018

1 reference

Serum autoantibodies to neurofilament proteins in sporadic amyotrophic lateral sclerosis.

21 January 2018

1 reference

IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis

21 January 2018

1 reference

Inflammation and neurovascular changes in amyotrophic lateral sclerosis.

21 January 2018

1 reference

Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis

21 January 2018

1 reference

Blood-CNS Barrier Impairment in ALS patients versus an animal model

21 January 2018

1 reference

Reduction of circulating endothelial cells in peripheral blood of ALS patients

21 January 2018

1 reference

A chemical chaperone-based drug candidate is effective in a mouse model of amyotrophic lateral sclerosis (ALS).

21 January 2018

1 reference

Amyotrophic lateral sclerosis-immunoglobulins selectively interact with neuromuscular junctions expressing P/Q-type calcium channels

21 January 2018

1 reference

Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis

21 January 2018

1 reference

Prion-like activity of Cu/Zn superoxide dismutase: implications for amyotrophic lateral sclerosis.

21 January 2018

1 reference

Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells

21 January 2018

1 reference

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

21 January 2018

1 reference

Innate immune activation in neurodegenerative disease

21 January 2018

1 reference

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival

21 January 2018

1 reference

Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue

21 January 2018

1 reference

TRPM7 and TRPM2-Candidate susceptibility genes for Western Pacific ALS and PD?

21 January 2018

1 reference

The structured core domain of B-crystallin can prevent amyloid fibrillation and associated toxicity

21 January 2018

1 reference

Differential diagnosis of amyotrophic lateral sclerosis from Guillain-Barré syndrome by quantitative determination of TDP-43 in cerebrospinal fluid.

21 January 2018

1 reference

Profiling the genes affected by pathogenic TDP-43 in astrocytes

21 January 2018

1 reference

Elevated serum autoantibody against high mobility group box 1 as a potent surrogate biomarker for amyotrophic lateral sclerosis

21 January 2018

1 reference

Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.

21 January 2018

1 reference

Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS.

21 January 2018

1 reference

NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients.

21 January 2018

1 reference

The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol

21 January 2018

1 reference

The blood-brain barrier in multiple sclerosis: microRNAs as key regulators.

21 January 2018

1 reference

Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis.

21 January 2018

1 reference

Amyotrophic lateral sclerosis - cell based therapy and novel therapeutic development

21 January 2018

1 reference

Immunization with a Myelin-Derived Antigen Activates the Brain's Choroid Plexus for Recruitment of Immunoregulatory Cells to the CNS and Attenuates Disease Progression in a Mouse Model of ALS.

21 January 2018

1 reference

The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.

21 January 2018

1 reference

Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

Prion-like Mechanism in Amyotrophic Lateral Sclerosis: are Protein Aggregates the Key?

21 January 2018

1 reference

The Neuroinflammatory Response in ALS: The Roles of Microglia and T Cells

21 January 2018

1 reference

Transactivation response DNA-binding protein 43 microvasculopathy in frontotemporal degeneration and familial Lewy body disease

21 January 2018

1 reference

Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2.

21 January 2018

1 reference

Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study

21 January 2018

1 reference

Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation

21 January 2018

1 reference

Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective.

21 January 2018

1 reference

Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis.

21 January 2018

1 reference

Amyotrophic lateral sclerosis with positive anti-acetylcholine receptor antibodies. Case report and review of the literature

21 January 2018

1 reference

Innate immunity in amyotrophic lateral sclerosis.

21 January 2018

1 reference

Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?

21 January 2018

1 reference

Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes.

21 January 2018

1 reference

Autoimmunity in amyotrophic lateral sclerosis: past and present

21 January 2018

1 reference

The Pathophysiologic Roles of TRPM7 Channel

21 January 2018

1 reference

Emerging mechanisms of molecular pathology in ALS

21 January 2018

1 reference

Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis

21 January 2018

1 reference

The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia

21 January 2018

1 reference

Necroptosis drives motor neuron death in models of both sporadic and familial ALS.

21 January 2018

1 reference

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis

21 January 2018

1 reference

Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype.

21 January 2018

1 reference

Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress

21 January 2018

1 reference

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

21 January 2018

1 reference

Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons.

21 January 2018

1 reference

Glia as primary drivers of neuropathology in TDP-43 proteinopathies

21 January 2018

1 reference

Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation.

21 January 2018

1 reference

Serum ferritin is elevated in amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

Extracellular wildtype and mutant SOD1 induces ER-Golgi pathology characteristic of amyotrophic lateral sclerosis in neuronal cells.

21 January 2018

1 reference

CSF glial markers correlate with survival in amyotrophic lateral sclerosis

21 January 2018

1 reference

PAMPs and DAMPs: signal 0s that spur autophagy and immunity

21 January 2018

1 reference

Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats

21 January 2018

1 reference

Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011.

21 January 2018

1 reference

Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis

21 January 2018

1 reference

LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis

21 January 2018

1 reference

Activation of an immune-regulatory macrophage response and inhibition of lung inflammation in a mouse model of COPD using heat-shock protein alpha B-crystallin-loaded PLGA microparticles.

21 January 2018

1 reference

Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial

21 January 2018

1 reference

Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes

21 January 2018

1 reference

Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis

21 January 2018

1 reference

The small heat shock proteins αB-crystallin and Hsp27 suppress SOD1 aggregation in vitro

21 January 2018

1 reference

Cyclooxygenases in the central nervous system: implications for treatment of neurological disorders

21 January 2018

1 reference

In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients

21 January 2018

1 reference

Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis

21 January 2018

1 reference

TDP-43 activates microglia through NF-κB and NLRP3 inflammasome.

21 January 2018

1 reference

Extracellular mutant SOD1 induces microglial-mediated motoneuron injury

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BPA.12352

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26780491%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference